Fig. 4From: Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysisKaplan-Meier analysis of treatment persistence with octreotide or lanreotide, patients with 180-day washout period (n = 663). Numbers above axis indicate subjects at risk. Survival indicates probability of patients continuing treatment. LAN lanreotide; OCT octreotideBack to article page